Citius Oncology, Inc. (CTOR) — Cash Flow Reinvestment Rate
Latest as of September 2024:
0.00x
Citius Oncology, Inc. (CTOR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2024, reinvesting $0.46 (capex $0.46 ) from operating cash flow of $900.29K. Explore Citius Oncology, Inc. (CTOR) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.46
Capex + Investments
Operating Cash Flow
$900.29K
USD
Capital Expenditures
$0.46
USD
Citius Oncology, Inc. Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Citius Oncology, Inc. across 1 annual periods. Also explore CTOR total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Citius Oncology, Inc. (2024–2024)
Year-by-year capital reinvestment analysis for Citius Oncology, Inc.. For live market cap and broader valuation context, see CTOR stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 39.57x | $5.00 Million | $126.35K | $4.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow